SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 14, 2007
MERIDIAN BIOSCIENCE, INC. |
(Exact name of registrant as specified in its charter) |
Ohio | 0-14902 | 31-0888197 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No. ) |
3471 River Hills Drive, Cincinnati, Ohio | 45244 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (513) 271-3700
Item 2.02. Results of Operations and Financial Condition.
On November 14, 2007, the Registrant issued a press release announcing its financial results for the fiscal quarter and year ended September 30, 2007. A copy of the press release is furnished as Exhibit 99 to this report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99 | Press Release dated November 14, 2007 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MERIDIAN BIOSCIENCE, INC. | |||
Date: November 20, 2007 | By: | /s/ Melissa Lueke | |
Melissa Lueke | |||
Vice President and Chief Financial Officer (Principal Accounting Officer) | |||